Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 16 2020 - 8:13AM
Isoray, Inc. (NYSE American: ISR), a medical technology
company and innovator in seed brachytherapy powering expanding
treatment options throughout the body, today announced that Chief
Executive Officer Lori Woods will present at the Oppenheimer Fall
Healthcare Life Sciences & MedTech Summit on Wednesday,
September 23 at 1:40 p.m. ET. CEO Woods and Chief Financial Officer
Jonathan Hunt will also host virtual one-on-one and group meetings
with institutional investors during the conference.
A live webcast of the presentation will be
available on Isoray’s Investor Relations section of the Company’s
website at https://isoray.com/investors/presentations/. An
on-demand replay of the presentation will be available shortly
after the conclusion of the presentation on the Investor Relations
section of the website and will be available for 90 days.
About IsorayIsoray, Inc., through its
subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131
brachytherapy seeds, which are expanding brachytherapy options
throughout the body. Learn more about this innovative Richland,
Washington company and explore the many benefits and uses of
Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter. Join us on Facebook.
Contact:
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Sep 2024 to Oct 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Oct 2023 to Oct 2024